Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global recombinant protein market was valued at USD 1.9 billion in 2023, driven by the increasing demand for effective drugs to treat chronic diseases across the globe. The market is expected to grow at a CAGR of 11.21% during the forecast period of 2024 and 2032, likely to attain a value of USD 5 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Recombinant proteins are synthesized using recombinant DNA methods, where a new gene sequence is produced and the coded protein is inserted into host organism such as bacteria, yeast, or animal cells to produce the protein. It involves gene cloning and transformation. It enables selection, expression, purification and study of the protein. Recombinant proteins are vital in medicine (for instance, insulin and monoclonal antibodies), research, industry, and agriculture because their quality is standardized, the expression level can be easily scaled up and fine-tuned according to the needs. In addition, the production can be customized depending on the specific application. It offers advantages like purity and offers advantages like cost efficiency, making it ideal for mass production.
Increased Application in Disease Management
Diseases like cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia are becoming more common, boosting the demand for recombinant proteins. Cancer is a highly common and fast-growing chronic disease among the major chronic diseases. The American Cancer Society (ACS) analysis from 2023 projected 1,958,310 and 609,820 deaths in United States, requiring effective and precise treatment alternatives to combat the condition. Recombinant proteins are also used in the treatments like such as chemotherapy, cell culture, western blot, animal cell culture, glycosylation, biotherapeutic products, and bioengineering, thereby, boosting the global market value.
Surge in Partnerships Between Leading Players to Meet Rising Recombinant Protein Market Demand
In January 2024, Nucleus Biologics, a top cell culture media provider, entered a deal with Core Biogenesis to distribute and manufacture affordable and sustainable recombinant proteins. Together, the two companies aim to work together and deliver better, cheaper reagents and media to the cell and gene therapy markets. As per the terms of agreement, Nucleus Biologics will act as a GMP manufacturer for Core Biogenesis’ recombinant proteins. Such partnerships are expected to shape the market landscape effectively, as it works to provide precise and affordable solutions to consumers.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends | Impact |
Focus on Personalized Medicine | The use of recombinant proteins is evolving the treatment of patients, along with the possibility of creating unique therapies. These proteins are critical in developing therapies based on genetic makeup, notably in cancer and inherited metabolic diseases. The special accuracy of recombinant proteins in such applications is not only more effective in the treatment of disease but also decreases the side effects of the therapy, making it safer and more effective. |
Adoption of Agricultural Biotechnology | These recombinant proteins are used in agricultural biotechnology as well. These proteins play a significant role in creating desirable transgenic crops characterized by resistance to pests, diseases, and drought, besides boosting their nutritional value. Recombinant proteins are also playing a role in the development of bio-pesticides and bio-fertilizers for sustainable agriculture and raising crop productivity. |
Increased Collaborations and Partnerships | Strategic collaborations and partnerships assuming greater significance in the recombinant protein market, intended to foster innovation. The biotechnology firms are collaborating to capitalize on synergistic capabilities, exchange new technologies, and accelerate development programs. They provide new access to markets, research, and development relief, as well as innovation. |
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Region
Hormones Lead the Market Based on Product Type
Based on product type, the market can be divided into growth factor and cytokines, hormones, enzymes, antibodies, immune checkpoint proteins, and recombinant regulatory proteins, among others. The hormones segment is likely to take lead, owing to its versatility, particularly in the areas of research and innovation, including the development of therapies for diseases including diabetes. Hormones are very essential in the body involved in treatment for various diseases. Moreover, ease of intake makes it a popular alternative amongst users, affecting the market dynamics significantly.
Biotechnology Industry is Anticipated to Have Largest Market Share Based on Application
Based on application, the market is divided into therapeutic, research, biotechnology Industry. Among these biotechnology industry is expected to hold a significant market share, as it widely applies recombinant proteins at the clinical stages of designing, testing, and manufacturing new drugs. Recombinant proteins are central to the development of biopharmaceuticals and translate research successes into production that is clinically scalable.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Various regions covered in the global market report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Based on the regional analysis, North America is projected to hold largest market share in the forecast period, driven by increasing prevalence of diseases like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, among others. Growth in research and development activities between key market stakeholders and governments to meet the rising need for efficient medicine and treatment is also play a critical role in boosting market value.
The Asia Pacific region is likely to grow at a faster rate, owing to factors such as increasing healthcare expenditure, the growing biotechnology sector, and the upsurge in interest in recombinant protein therapies. For instance, in May 2023, Thermo Fisher Scientific Inc., and National Research and Innovation Agency (BRIN) entered the Memorandum of Understanding (MOU) with the aim of strengthening the Indonesian research and innovation systems and capacities. The partnership was aimed at helping and supporting country-level research and innovation institutions and their capacities towards improving scientific activity and the Indonesian economy. The collaboration can be viewed as a move towards enhancing the capacity of Indonesia to contribute and advance in the global realm of research and innovation.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis along with strategic initiatives by the key players. The major companies in the market are as follows:
Abcam PLC
Founded in 1998, this company occupies a premier position in the market dealing in protein research tools. The specific areas of expertise crafted by the company include primary antibodies and secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging reagents, among others.
Thermo Fisher Scientific, Inc.,
Known as one of the largest biotechnology research companies, it is based in Massachusetts, United States. The company operates in different sectors, which include analytical instruments, lab supply chain services and e-business solutions, general lab equipment and services, specialty diagnostics, life science records, pharma solutions, contract development, and manufacturing organization.
Bio-Techne Corp.
This United States based company is a provider of purified proteins and reagent solutions to customers in pharmaceuticals and other specialty markets. It is also involved in protein analysis solutions, like analyzing solutions services and produces antibodies, enzymes, proteins, cell culture reagents, and others.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is a leading global pharmaceutical firm with a functional base in Basel, Switzerland; the firm operates in recombinant proteins, among many others. It works in different therapeutic segments, which include oncology, immunology, and infectious disease.
Other companies in the market include Abbott, Merck KGaA, Bio-Rad Laboratories, Inc., GeneTex, Inc, Lonza Group SA, PerkinElmer Inc., Sino Biological Inc., TAKARA HOLDINGS INC., Tosoh Corporation, XENOTECH AI Pvt Ltd., and NEW ENGLAND BIOLABS, INC.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Recombinant Protein Market Size
Recombinant Protein Market Growth
Recombinant Protein Market Trends
Recombinant Protein Market Share
Recombinant Protein Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share